FDA Approval: Economics, Not Science? Unpacking the System Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and Why would a patient trust a peptide more than a statin? STAT Warning: BPC 157 is a synthetic peptide and an unapproved drug, often promoted with misleading claims. It is prohibited and on the DoD Prohibited Dietary Supplement Ingredients List. Don't gamble with your